Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial

Vaccination against SARS-CoV-2 was associated with reduced Covid-19 symptom severity in a sample of low to moderate risk adults who were enrolled in an outpatient Covid-19 treatment trial. Boosting was associated with further reduction in symptoms . Graphical Abstract

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2022-09
Hauptverfasser: Boulware, David R, Murray, Thomas A, Proper, Jennifer L, Tignanelli, Christopher J, Buse, John B, Liebovitz, David M, Nicklas, Jacinda M, Cohen, Kenneth, Puskarich, Michael A, Belani, Hrishikesh K, Siegel, Lianne K, Klatt, Nichole R, Odde, David J, Karger, Amy B, Ingraham, Nicholas E, Hartman, Katrina M, Rao, Via, Hagen, Aubrey A, Patel, Barkha, Fenno, Sarah L, Avula, Nandini, Reddy, Neha V, Erickson, Spencer M, Lindberg, Sarah, Fricton, Regina, Lee, Samuel, Zaman, Adnin, Saveraid, Hanna G, Tordsen, Walker J, Pullen, Matthew F, Sherwood, Nancy E, Huling, Jared D, Bramante, Carolyn T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Vaccination against SARS-CoV-2 was associated with reduced Covid-19 symptom severity in a sample of low to moderate risk adults who were enrolled in an outpatient Covid-19 treatment trial. Boosting was associated with further reduction in symptoms . Graphical Abstract
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciac772